DIETARY_SUPPLEMENT · Unmapped registry intervention
Palmitoleic acid
Find medicine records ·
Find other trials using this name
Clinical trial
Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes
NCT05560971
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMonounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
PreDiabetesverified · MONDO: prediabetes syndrome
Insulin Resistanceunresolved
Overweightunresolved
Obesityverified · MONDO: obesity disorder
Interventions
Palmitoleic acidDIETARY_SUPPLEMENT
PlaceboOTHER
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Tersus Life Sciences LLCcollaborator
Istanbul Nisantasi Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05560971 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.